Feb. 3, 2014, 2:25 AM
Jan. 8, 2014, 2:09 PM
- "We believe the stock will trade less on fundamentals and more on the take-out potential, [so] we once again put pen to paper to provide clarity on what we feel the different buyers are willing/able to pay," Canaccord says, regarding the outlook for ArthroCare (ARTC +18.8%) in the wake of the DPA announced Tuesday.
- Analyst William Plovanic says the shares could be valued at "above $55 for an acquirer that planned on keeping most infrastructure."
- For potential suitors with "existing infrastructure in sports med and ENT," Plovanic sees $80+.
Jul. 2, 2013, 9:29 AM
ArthroCare (ARTC) acquires privately held ENTrigue Surgical for $45M in cash. (PR)| Jul. 2, 2013, 9:29 AM
Apr. 28, 2011, 10:37 AM
Johnson & Johnson’s (JNJ -0.9%) newfound dominance of the orthopedic device market from its $21.3B acquisition of Synthes may pressure rivals Zimmer (ZMH +3.3%) and Stryker (SYK +0.2%) to seek purchases of their own among smaller ortho companies. Potential targets: ARTC, BMTI, WMGI.| Apr. 28, 2011, 10:37 AM